InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（9 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
9
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Inrig Jula, Directeur Médical. Officer active across 1 company, notably Travere Therapeutics, Inc.. Cumulatively, 18 reports have been logged. Breakdown: 0 buy · 9 sells. Total volume traded: €520k. Activity tracked since 1 January 2022. The latest transaction was filed on 13 April 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Inrig Jula
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
14,000 股0Common StockSEC:0001902368-26-000005:0
7,215 股@ US$41.92880.0054% mcap64.4% 占其流量Common StockSEC:0001902368-26-000005:1
1,018 股@ US$42.610.0008% mcap9.2% 占其流量Common StockSEC:0001902368-26-000005:2
1,547 股@ US$32.116.6% 占其流量Common StockSEC:0001902368-26-000004:0
28,130 股0Common StockSEC:0001902368-26-000003:0
2,031 股@ US$40.1811.0% 占其流量Common StockSEC:0001902368-26-000002:0
15,000 股@ US$8.9321.8% 占其流量Common StockSEC:0001902368-25-000005:0
815 股@ US$14.652.5% 占其流量Common StockSEC:0001415889-25-019108:0
8,000 股Common StockSEC:0001415889-25-003819:0
30,000 股0Common StockSEC:0001415889-25-003064:0
2,066 股@ US$19.1036.7% 占其流量Common StockSEC:0001415889-25-000899:0
684 股@ US$12.987.7% 占其流量Common StockSEC:0001415889-24-023128:0
6,750 股0Common StockSEC:0001415889-24-023093:0
25,000 股0Common StockSEC:0001415889-24-002281:0
2,069 股@ US$9.479417.1% 占其流量Common StockSEC:0001209191-24-001005:0
20,250 股0Common StockSEC:0001209191-23-006420:0
2,051 股@ US$20.7538.5% 占其流量Common StockSEC:0001209191-23-002325:0
20,000 股0Common StockSEC:0001209191-22-001117:0
18 条申报中的 18 条
About Inrig Jula
Inrig Jula is Chief Medical Officer at Travere Therapeutics, Inc. Across 18 filings in total, the 18 sampled filings cover the period from 2022-01-04 to 2026-04-15 and show EUR 519750 of sales, with Cession as the modal transaction nature.
